(Q38068294)

28 August 2017

Vitamin K dosing to reverse warfarin based on INR, route of administration, and home warfarin dose in the acute/critical care setting (English)

1 reference

28 August 2017

0 references

1 reference

1 reference

Laura V Tsu

1

1 reference

28 August 2017

J Erin Dienes

series ordinal

2

1 reference

28 August 2017

William E Dager

series ordinal

3

1 reference

28 August 2017

language of work or name

English

0 references

publication date

18 December 2012

1 reference

Annals of Pharmacotherapy

28 August 2017

1 reference

28 August 2017

46

1 reference

28 August 2017

12

1 reference

28 August 2017

1617-1626

1 reference

Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

28 August 2017

1 reference

Treatment of coumarin-associated coagulopathy: a systematic review and proposed treatment algorithms.

21 January 2018

1 reference

Warfarin anticoagulation reversal: management of the asymptomatic and bleeding patient

21 January 2018

1 reference

The risk of hemorrhage among patients with warfarin-associated coagulopathy

21 January 2018

1 reference

Anticoagulation intensity and outcomes among patients prescribed oral anticoagulant therapy: a systematic review and meta-analysis

21 January 2018

1 reference

Urgent reversal of vitamin K antagonist therapy

21 January 2018

1 reference

Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

21 January 2018

1 reference

Comparison of oral vs intravenous phytonadione (vitamin K1) in patients with excessive anticoagulation: a prospective randomized controlled study

21 January 2018

1 reference

A comparison of the efficacy and rate of response to oral and intravenous Vitamin K in reversal of over-anticoagulation with warfarin

21 January 2018

1 reference

A prospective randomized study to determine the optimal dose of intravenous vitamin K in reversal of over-warfarinization.

21 January 2018

1 reference

Low-Dose Vitamin K Therapy in Excessively Anticoagulated Patients: A Dose-Finding Study

21 January 2018

1 reference

Treatment of warfarin-associated coagulopathy with oral vitamin K: a randomised controlled trial.

21 January 2018

1 reference

A randomized trial comparing 1 mg of oral vitamin K with no treatment in the management of warfarin-associated coagulopathy in patients with mechanical heart valves

21 January 2018

1 reference

Randomized, placebo-controlled trial of oral phytonadione for excessive anticoagulation.

21 January 2018

1 reference

The incidence of anaphylaxis following intravenous phytonadione (vitamin K1): a 5-year retrospective review

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1R497

1 reference

28 August 2017

1 reference